Trial intelligence / Profile preview

Sabin strain inactivated poliovirus vaccine dose-ranging study in 2-month-old infants

CTR20160760Phase 2Completed

Sponsor
Wuhan Institute of Biological Products
Start
Jul 2017
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Wuhan Institute of Biological Products. Started Jul 2017; status: completed.

02

Drugs

Sabin strain inactivated poliovirus vaccine
03

Conditions

poliomyelitis

Beyond the preview

Go deeper on CTR20160760.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160760.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call